Biomolecular Recognition and Immobilization are fundamental processes in biotechnology and biochemistry that involve the specific binding and attachment of biomolecules to surfaces or other molecules. These processes play crucial roles in various applications, including biosensors, diagnostics, drug discovery, and biocatalysis. Biomolecular recognition refers to the selective interaction between biomolecules, such as proteins, nucleic acids, or carbohydrates, and their complementary binding partners, driven by specific molecular recognition events, such as hydrogen bonding, electrostatic interactions, or hydrophobic interactions. This recognition enables the precise and selective detection, capture, or manipulation of target biomolecules in complex biological samples. Immobilization involves the attachment or confinement of biomolecules to solid supports, matrices, or surfaces, thereby enhancing their stability, functionality, and accessibility for various applications. Immobilization strategies can range from physical adsorption or entrapment to covalent attachment or affinity-based methods, depending on the desired properties and applications of the immobilized biomolecules. Immobilization techniques not only facilitate the handling and manipulation of biomolecules but also enable the development of robust and reusable bio analytical platforms and bio catalytic systems.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States